These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 2471199)

  • 41. Inhibition of human immunodeficiency virus type 1 by packageable, multigenic antisense RNA.
    Shahabuddin M; Khan AS
    Antisense Nucleic Acid Drug Dev; 2000 Jun; 10(3):141-51. PubMed ID: 10905551
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antisense phosphorothioate oligodeoxynucleotides alter HIV type 1 replication in cultured human macrophages and peripheral blood mononuclear cells.
    Weichold FF; Lisziewicz J; Zeman RA; Nerurkar LS; Agrawal S; Reitz MS; Gallo RC
    AIDS Res Hum Retroviruses; 1995 Jul; 11(7):863-7. PubMed ID: 7546914
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Inhibition of expression of human immunodeficiency virus-1 in vitro by antibody-targeted liposomes containing antisense RNA to the env region.
    Renneisen K; Leserman L; Matthes E; Schröder HC; Müller WE
    J Biol Chem; 1990 Sep; 265(27):16337-42. PubMed ID: 1697856
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Rev activity determines sensitivity of HIV-1-infected primary T cells to CTL killing.
    Bobbitt KR; Addo MM; Altfeld M; Filzen T; Onafuwa AA; Walker BD; Collins KL
    Immunity; 2003 Feb; 18(2):289-99. PubMed ID: 12594955
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The art gene product of human immunodeficiency virus is required for replication.
    Terwilliger E; Burghoff R; Sia R; Sodroski J; Haseltine W; Rosen C
    J Virol; 1988 Feb; 62(2):655-8. PubMed ID: 3257271
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A comparison of gag, pol and rev antisense oligodeoxynucleotides as inhibitors of HIV-1.
    Kinchington D; Galpin S; Jaroszewski JW; Ghosh K; Subasinghe C; Cohen JS
    Antiviral Res; 1992 Jan; 17(1):53-62. PubMed ID: 1736810
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Immunodeficiency virus rev trans-activator modulates the expression of the viral regulatory genes.
    Malim MH; Hauber J; Fenrick R; Cullen BR
    Nature; 1988 Sep; 335(6186):181-3. PubMed ID: 3412474
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Constitutive expression of chimeric neo-Rev response element transcripts suppresses HIV-1 replication in human CD4+ T lymphocytes.
    Bevec D; Volc-Platzer B; Zimmermann K; Dobrovnik M; Hauber J; Veres G; Böhnlein E
    Hum Gene Ther; 1994 Feb; 5(2):193-201. PubMed ID: 8186299
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Trafficking through the Rev/RRE pathway is essential for efficient inhibition of human immunodeficiency virus type 1 by an antisense RNA derived from the envelope gene.
    Ward AM; Rekosh D; Hammarskjold ML
    J Virol; 2009 Jan; 83(2):940-52. PubMed ID: 18971264
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antiviral effects of human immunodeficiency virus type 1-specific small interfering RNAs against targets conserved in select neurotropic viral strains.
    Dave RS; Pomerantz RJ
    J Virol; 2004 Dec; 78(24):13687-96. PubMed ID: 15564478
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Immune stimulation by an antisense oligomer complementary to the rev gene of HIV-1.
    Branda RF; Moore AL; Mathews L; McCormack JJ; Zon G
    Biochem Pharmacol; 1993 May; 45(10):2037-43. PubMed ID: 8512586
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mathematical model of the Tat-Rev regulation of HIV-1 replication in an activated cell predicts the existence of oscillatory dynamics in the synthesis of viral components.
    Likhoshvai VA; Khlebodarova TM; Bazhan SI; Gainova IA; Chereshnev VA; Bocharov GA
    BMC Genomics; 2014; 15 Suppl 12(Suppl 12):S1. PubMed ID: 25564443
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Inhibition of HIV-1 replication by chimeric phosphorothioate oligodeoxynucleotides applied in free solution.
    Lund OS; Hansen JE
    Intervirology; 1998; 41(2-3):63-8. PubMed ID: 9820839
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Inhibition of HIV-1 replication by novel lentiviral vectors expressing transdominant Rev and HIV-1 env antisense.
    Mautino MR; Morgan RA
    Gene Ther; 2002 Apr; 9(7):421-31. PubMed ID: 11938457
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Intracellular expression of antisense RNA transcripts complementary to the human immunodeficiency virus type-1 vif gene inhibits viral replication in infected T-lymphoblastoid cells.
    Barnor JS; Miyano-Kurosaki N; Yamaguchi K; Sakamoto A; Ishikawa K; Inagaki Y; Yamamoto N; Osei-Kwasi M; Ofori-Adjei D; Takaku H
    Biochem Biophys Res Commun; 2004 Jul; 320(2):544-50. PubMed ID: 15219863
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Inhibition of human immunodeficiency virus type 1 (HIV) gag gene expression by an antisense oligodeoxynucleotide phosphorothioate.
    Anazodo MI; Wainberg MA; Friesen AD; Wright JA
    Leukemia; 1995 Oct; 9 Suppl 1():S86-8. PubMed ID: 7475322
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Expression of the art/trs protein of HIV and study of its role in viral envelope synthesis.
    Knight DM; Flomerfelt FA; Ghrayeb J
    Science; 1987 May; 236(4803):837-40. PubMed ID: 3033827
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Inhibition of human immunodeficiency virus type 1 (HIV-1) replication by HIV-1-based lentivirus vectors expressing transdominant Rev.
    Mautino MR; Keiser N; Morgan RA
    J Virol; 2001 Apr; 75(8):3590-9. PubMed ID: 11264348
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Human immunodeficiency virus type 1 regulator of virion expression, rev, forms nucleoprotein filaments after binding to a purine-rich "bubble" located within the rev-responsive region of viral mRNAs.
    Heaphy S; Finch JT; Gait MJ; Karn J; Singh M
    Proc Natl Acad Sci U S A; 1991 Aug; 88(16):7366-70. PubMed ID: 1871141
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Trans-activating rev protein of the human immunodeficiency virus 1 interacts directly and specifically with its target RNA.
    Daefler S; Klotman ME; Wong-Staal F
    Proc Natl Acad Sci U S A; 1990 Jun; 87(12):4571-5. PubMed ID: 2191294
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.